Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DFTX Definium Therapeutics

Post-Mkt 07-21 18:32:49 EDT

45.08

+2.28

+5.33%

盘后44.81

-0.27-0.60%

18:14 EDT

High45.17	Low41.57	Vol1.50M
Open42.49	D1 Closing42.80	Amplitude8.41%
Mkt Cap5.86B	Tradable Cap5.64B	Total Shares130.00M
T/O66.32M	T/O Rate1.20%	Tradable Shares125.13M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":45.08,"timestamp":1784664000000,"preClose":42.8,"halted":0,"volume":1498043,"hourTrading":{"tag":"盘后","latestPrice":44.81,"preClose":45.08,"latestTime":"18:14 EDT","volume":26344,"amount":1187315.728952,"timestamp":1784672086620,"change":-0.27,"changeRate":-0.005989,"amplitude":0.013531},"delay":0,"changeRate":0.053271028037383206,"floatShares":125130818,"shares":130000000,"eps":-2.49367,"marketStatus":"Post-Mkt","change":2.28,"latestTime":"07-21 18:32:49 EDT","open":42.49,"high":45.17,"low":41.57,"amount":66322838.264441,"amplitude":0.084112,"askPrice":45.41,"askSize":20,"bidPrice":44.81,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-2.49367,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1784678400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":42.8,"preHourTrading":{"tag":"盘前","latestPrice":42,"preClose":42.8,"latestTime":"09:28 EDT","volume":1799,"amount":76972.39179,"timestamp":1784640481467,"change":-0.8,"changeRate":-0.018692,"amplitude":0.051168},"postHourTrading":{"tag":"盘后","latestPrice":44.81,"preClose":45.08,"latestTime":"18:14 EDT","volume":26344,"amount":1187315.728952,"timestamp":1784672086620,"change":-0.27,"changeRate":-0.005989,"amplitude":0.013531},"volumeRatio":0.830111,"impliedVol":1.1624,"impliedVolPercentile":0.7638},"requestUrl":"/m/hq/s/DFTX/wiki","defaultTab":"wiki","newsList":[{"id":"1171650657","title":"Movement Alert｜Definium Therapeutics Rises 5.14% in Regular Trading, Trading at $45.02","url":"https://stock-news.laohu8.com/highlight/detail?id=1171650657","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171650657?lang=en_us&edition=fundamental","pubTime":"2026-07-22 03:50","pubTimestamp":1784663440,"startTime":"0","endTime":"0","summary":"On July 22, Definium Therapeutics rose 5.14% in regular trading, trading at $45.02/share, with Turnover of $39.52 million.Within the Pharmacy sector where Definium Therapeutics belongs, the overall...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653704243","title":"Definium Therapeutics Issues Options for 30,330 Shares to New Hires Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2653704243","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653704243?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:01","pubTimestamp":1784577692,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues options for 30,330 shares to new hires under inducement planDefinium Therapeutics issued inducement stock options covering 30,330 common shares to two newly hired non-exec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDLKfSXl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173601696","title":"Movement Alert｜Definium Therapeutics Rises 5.5% in Regular Trading, DT120 Phase 3 Data and Sector M&A Fuel Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1173601696","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173601696?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:43","pubTimestamp":1784209420,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 5.5% in regular trading, trading at $46.5/share, with turnover of $24.58 million.On the news front, multiple catalysts continue to support buying momentum. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Definium Therapeutics Rises, DT120 Phase 3 Data and Secto...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449575","title":"S&P 500 Futures Decline in Premarket Trading; Ermenegildo Zegna, JB Hunt Transport Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651449575?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:30","pubTimestamp":1784201400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Ermenegildo Zegna N.V. (ZGN) was up 10.9% in pre-mark","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTF","PEGA","BKLC","MRCP","VOO","VOOG","VUG","UNH","ISSXF","XPAY","ZGN","SPGP","FLAO","DBB","ASTS","CPST","ACLC","PTL","VHT","XUSP","HELO","CGUS","CFO","DFTX","FLCC","IJH","SNDK","SPY","LGH","OALC","IYH","GBXB","PBJL","TSPA","UOCT",".SPX","FEBT","SPYM","GSUS","LOHA","SCHG","VYM","GPIX","PTLC","UXJA","ETFT","JBHT","BMAY","FELC","SPYU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651319446","title":"Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (gad) Patient Impact and Neurobiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2651319446","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651319446?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA2VFM6H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147939149","title":"Movement Alert｜Definium Therapeutics Rises 5.1% in Pre-Market Trading, DT120 Phase 3 Data and Capital Raise Continue to Fuel Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1147939149","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147939149?lang=en_us&edition=fundamental","pubTime":"2026-07-16 16:47","pubTimestamp":1784191651,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 5.1% in pre-market trading, trading at $48.0/share, with turnover of $62,900. The stock continues to rally as multiple positive catalysts sustain buying...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Definium Therapeutics Rises, DT120 Phase 3 Data and Ca...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158920231","title":"Movement Alert｜Definium Therapeutics Rises 7.03% Overnight, DT120 Phase 3 Data Momentum Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1158920231","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158920231?lang=en_us&edition=fundamental","pubTime":"2026-07-16 08:48","pubTimestamp":1784162901,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 7.03% overnight, trading at $48.87 per share, with turnover of $19,100.The continued upward momentum is driven by the sustained positive market reaction to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142890561","title":"Movement Alert｜Definium Therapeutics Rises 5.04% in After-Hours Trading, Trading at $47.79","url":"https://stock-news.laohu8.com/highlight/detail?id=1142890561","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142890561?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:58","pubTimestamp":1784156317,"startTime":"0","endTime":"0","summary":"On July 16, Definium Therapeutics rose 5.04% in after-hours trading, trading at $47.79 USD/share, with Turnover of $1.4192 million.Within the Pharmacy sector where Definium Therapeutics belongs,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111494","title":"Definium Therapeutics (DFTX) Could Be 30% Overvalued After New GAD Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111494","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111494?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:27","pubTimestamp":1784154476,"startTime":"0","endTime":"0","summary":"What the new GAD study tells investors about Definium Therapeutics stock\nDefinium Therapeutics (DFTX) has put fresh clinical needs in the spotlight with a large healthcare claims study in CNS Spectrums showing many generalized anxiety disorder patients discontinuing or switching treatment far earlier than guidelines suggest.\nFor you as an investor, the findings matter because they quantify how often real world patients move away from current generalized anxiety disorder therapies or...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-could-be-30-overvalued-after-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-could-be-30-overvalued-after-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651486358","title":"Will New GAD Treatment Persistence Data Change Definium Therapeutics' (DFTX) Unmet‑Need Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651486358","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651486358?lang=en_us&edition=fundamental","pubTime":"2026-07-15 02:43","pubTimestamp":1784054639,"startTime":"0","endTime":"0","summary":"Definium Therapeutics recently reported results from a large U.S. healthcare claims study, published in CNS Spectrums, examining real‑world pharmacotherapy patterns in adults with generalized anxiety disorder between 2020 and 2024.\nThe analysis revealed frequent early discontinuation, rapid switching, and prolonged gaps in care, underscoring substantial unmet need and limited durability of benefit with current GAD treatment options.\nNext, we will explore how this evidence of high...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/will-new-gad-treatment-persistence-data-change-definium-ther","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/will-new-gad-treatment-persistence-data-change-definium-ther","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126761817","title":"Movement Alert｜Definium Therapeutics Rises 5.13% in Regular Trading, Trading at $45.845","url":"https://stock-news.laohu8.com/highlight/detail?id=1126761817","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126761817?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:38","pubTimestamp":1784047137,"startTime":"0","endTime":"0","summary":"On July 14, Definium Therapeutics rose 5.13% in regular trading, trading at $45.845 USD/share, with Turnover of $23.838 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651965170","title":"Definium Therapeutics announces results from healthcare claims study in GAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2651965170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651965170?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:11","pubTimestamp":1784027482,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced results from a new healthcare claims study of treatment patterns of newly diagnosed and established GAD pati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-results-from-healthcare-claims-study-in-gad-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-announces-results-from-healthcare-claims-study-in-gad-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","TCAF","VHT","IXJ","DFTX","CGCV","BK4588","NOBL","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651779631","title":"Definium Says Claims Study Finds High GAD Drug Discontinuation, Switching Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2651779631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651779631?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:00","pubTimestamp":1784026838,"startTime":"0","endTime":"0","summary":"Definium says claims study finds high GAD drug discontinuation, switching ratesDefinium Therapeutics reported results from a healthcare claims study in CNS Spectrums showing high switching, discontinu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL3nF15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113461683","title":"Movement Alert｜Definium Therapeutics Falls 5.44% in Regular Trading, Trading at $44.45","url":"https://stock-news.laohu8.com/highlight/detail?id=1113461683","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113461683?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:22","pubTimestamp":1783952568,"startTime":"0","endTime":"0","summary":"On July 13, Definium Therapeutics fell 5.44% in regular trading, trading at $44.45 USD/share, with Turnover of $13.26 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171789885","title":"Movement Alert｜Definium Therapeutics Falls 5.06% in Regular Trading, Trading at $45.96","url":"https://stock-news.laohu8.com/highlight/detail?id=1171789885","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171789885?lang=en_us&edition=fundamental","pubTime":"2026-07-10 21:52","pubTimestamp":1783691561,"startTime":"0","endTime":"0","summary":"On July 10, Definium Therapeutics fell 5.06% in regular trading, trading at $45.96 USD/share, with Turnover of $9.66 million.Within the Pharmacy sector where Definium Therapeutics belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192883916","title":"Movement Alert｜Definium Therapeutics Rises 5.09% in Regular Trading, Phase 3 Clinical Success and Major Financing Boost Market Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1192883916","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192883916?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:54","pubTimestamp":1783612460,"startTime":"0","endTime":"0","summary":"On July 9, Definium Therapeutics rose 5.09% in regular trading, trading at $47.34 per share with turnover of $67.50 million.The rally continues to be driven by the companys core product DT120 orally...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649998253","title":"Definium Therapeutics price target raised to $60 from $30 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2649998253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649998253?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:11","pubTimestamp":1783509077,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Definium Therapeutics (DFTX) to $60 from $30 and keeps a Buy rating on the shares. Better-than-expected MD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-60-from-30-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-60-from-30-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649607819","title":"Definium Therapeutics Inc : Stifel Raises Target Price to $60 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2649607819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649607819?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:58","pubTimestamp":1783508324,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649529958","title":"Definium Therapeutics (DFTX) Following Russell Index Removal And The Fair Value Debate","url":"https://stock-news.laohu8.com/highlight/detail?id=2649529958","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649529958?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:42","pubTimestamp":1783456965,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) has attracted fresh attention after being removed from several Russell indexes, a shift that can influence index linked trading, liquidity, and how some investors view the stock.\nSee our latest analysis for Definium Therapeutics.\nDespite the index removals and recent inducement grants, Definium Therapeutics has seen strong momentum build over recent months, with a 30 day share price return of 88.24%, a 90 day share price return of 115.40% and a year to date share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-following-russell-index-removal-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-following-russell-index-removal-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DFTX","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679972","title":"Definium Therapeutics Issues Inducement Stock Options for 169,740 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679972","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679972?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:01","pubTimestamp":1783368080,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 169,740 shares to new hiresDefinium Therapeutics issued inducement stock options covering 169,740 common shares to eight newly hired non-execu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL72SgMh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":0.7484},{"period":"3month","weight":0.7953},{"period":"6month","weight":1.4956},{"period":"1year","weight":3.8198},{"period":"ytd","weight":2.1964}],"compareEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0062},{"period":"3month","weight":0.054},{"period":"6month","weight":0.0827},{"period":"1year","weight":0.1825},{"period":"ytd","weight":0.0882}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.037703},{"month":5,"riseRate":0.5,"avgChangeRate":0.01554},{"month":6,"riseRate":0.5,"avgChangeRate":0.064762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.158003},{"month":8,"riseRate":0.2,"avgChangeRate":-0.091548},{"month":9,"riseRate":0.2,"avgChangeRate":-0.174855},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}